Research graph
References from Leukocytosis, prognosis biomarker in locally advanced head and neck cancer patients after chemoradiotherapy. Local targets link to admitted publications; unresolved targets remain external evidence.
Advances in radiotherapy of head and neck cancers
10.1097/cco.0b013e3283388906 · 2010 · External reference
An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer
10.1200/jco.2003.01.008 · 2003 · External reference
Concurrent use of cisplatin or cetuximab with definitive radiotherapy for locally advanced head and neck squamous cell carcinomas
10.1007/s00066-014-0626-0 · 2014 · External reference
Concurrent chemoradiotherapy with cisplatin or cetuximab for locally advanced head and neck squamous cell carcinomas: does human papilloma virus play a role?
10.1016/j.oraloncology.2016.05.019 · 2016 · External reference
Inflammation and cancer
10.1038/nature01322 · 2002 · External reference
Can immunostimulatory agents enhance the abscopal effect of radiotherapy?
1990 · External reference
Modulation of neutrophil granulocytes in the tumor microenvironment: Mechanisms and consequences for tumor progression
10.1016/j.semcancer.2013.02.005 · 2013 · External reference
Human Papillomavirus and survival of patients with oropharyngeal cancer
10.1056/nejmoa0912217 · 2010 · External reference
Pretreatment leukocytosis is an indicator of poor prognosis in patients with cervical cancer
10.1016/j.ygyno.2011.03.037 · 2011 · External reference
The prognostic significance of pretreatment leukocytosis in patients with anal cancer treated with radical chemoradiotherapy or radiotherapy
10.1097/dcr.0b013e31829ab0d4 · 2013 · External reference
Neutrophil-to-lymphocyte ratio and overall survival in all sites of head and neck squamous cell carcinoma: neutrophils and lymphocytes: prognostic value in HNSCC
10.1002/hed.24159 · 2016 · External reference
Pretreatment neutrophil to lymphocyte ratio is associated with response to therapy and prognosis of advanced non-small cell lung cancer patients treated with first-line platinum-based chemotherapy
10.1007/s00262-012-1347-9 · 2013 · External reference
Impact of cisplatin dose intensity on human papillomavirus-related and -unrelated locally advanced head and neck squamous cell carcinoma
10.1016/j.ejca.2016.08.013 · 2016 · External reference
Prognostic value of hypercalcaemia and leucocytosis in resected oral squamous cell carcinoma
10.1016/j.bjoms.2014.02.014 · 2014 · External reference
Etiology and outcome of extreme leukocytosis in 758 nonhematologic cancer patients: a retrospective, single-institution study
10.1002/cncr.24480 · 2009 · External reference
Pretreatment lymphocyte-to-monocyte ratio as an independent prognostic factor for head and neck cancer
2016 · External reference
Pretreatment count of peripheral neutrophils, monocytes, and lymphocytes as independent prognostic factor in patients with head and neck cancer: peripheral neutrophils, monocytes, and lymphocytes in HNSCC
2016 · External reference
Prognostic value of pretreatment circulating neutrophils, monocytes, and lymphocytes in oropharyngeal cancer stratified by human papillomavirus status: leukocyte and oropharyngeal cancer outcomes
10.1002/cncr.29100 · 2015 · External reference
Immune-based mechanisms of cytotoxic chemotherapy: implications for the design of novel and rationale-based combined treatments against cancer
10.1038/cdd.2013.67 · 2014 · External reference
Prognostic value of nutritional and hematologic markers in head and neck squamous cell carcinoma treated by chemoradiotherapy
10.1016/j.radonc.2015.10.029 · 2016 · External reference
Systemic inflammation is an independent predictive marker of clinical outcomes in mucosal squamous cell carcinoma of the head and neck in oropharyngeal and non-oropharyngeal patients
10.1186/s12885-016-2089-4 · 2016 · External reference
Prognostic value of the neutrophil-to-lymphocyte ratio in patients with laryngeal squamous cell carcinoma: neutrophil-to-lymphocyte ratio in laryngeal cancer
10.1002/hed.24346 · 2016 · External reference
The systemic inflammation-based neutrophil–lymphocyte ratio: experience in patients with cancer
10.1016/j.critrevonc.2013.03.010 · 2013 · External reference
Clinicopathological study of involvement of granulocyte colony stimulating factor and granulocyte-macrophage colony stimulating factor in non-lymphohematopoietic malignant tumors accompanied by leukocytosis
2002 · External reference
Neutrophils in cancer: neutral no more
10.1038/nrc.2016.52 · 2016 · External reference
Recruitment of myeloid but not endothelial precursor cells facilitates tumor regrowth after local irradiation
10.1158/0008-5472.can-09-4446 · 2010 · External reference
Influence of bone marrow-derived hematopoietic cells on the tumor response to radiotherapy: experimental models and clinical perspectives
10.4161/cc.8.7.8075 · 2009 · External reference
Severe anemia is associated with poor tumor oxygenation in head and neck squamous cell carcinomas
10.1016/s0360-3016(99)00384-3 · 2000 · External reference
Oxygenation of head and neck cancer: changes during radiotherapy and impact on treatment outcome
10.1016/s0167-8140(99)00102-4 · 1999 · External reference
Prognostic significance of a pretreatment hematologic profile in patients with head and neck cancer
10.1007/s00432-009-0625-1 · 2009 · External reference
Cumulative cisplatin dose in concurrent chemoradiotherapy for head and neck cancer: a systematic review: cumulative cisplatin dose in head and neck cancer chemoradiotherapy
10.1002/hed.24026 · 2016 · External reference
PAPILLOPHAR: impact of the human papillomavirus (HPV) status in the prognosis of oropharynx squamous cell carcinoma (OSCC)
10.1200/jco.2011.29.15_suppl.tps198 · 2011 · External reference
